Ozampi's domestic analogue became the winner of the "Product of the Year" award.
The drug Semavik Next by Gerofram received an award in the "Consumer Trust" category. It occupies 50.1% of the Russian semaglutide market and is the most studied drug in the GLP-1 category in the country.
The national award "Product of the Year" is awarded annually to the manufacturers of the most popular consumer products.
Sign up for today's torch in Max.
We distribute Lanta merchandise.